 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - KalVista Pharmaceuticals Inc. (KALV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-10-29 Sale | 2020-11-02 8:01 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $17.48 | $87,394 | 62,969 (Direct) | View |
| 2020-10-30 Purchase | 2020-11-03 7:56 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 115,686 | $17.24 | $1,994,068 | 1,138,179 (Indirect) | View |
| 2020-11-02 Sale | 2020-11-04 5:03 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $17.14 | $102,812 | 72,734 (Direct) | View |
| 2020-12-30 Sale | 2021-01-04 6:06 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $20.04 | $7,175 | 32,500 (Direct) | View |
| 2021-01-04 Sale | 2021-01-06 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $18.19 | $181,904 | 185,420 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:20 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $33.55 | $335,538 | 169,420 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:22 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 31,000 | $33.6 | $1,041,642 | 54,234 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:23 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 29,642 | $33.59 | $995,562 | 65,000 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 15,000 | $33.59 | $503,877 | 47,969 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 6:38 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $27.44 | $274,436 | 159,420 (Direct) | View |
| 2021-04-27 Sale | 2021-04-29 8:55 pm | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 88,030 | $25.28 | $2,225,736 | 0 (Direct) | View |
| 2021-04-28 Sale | 2021-04-30 5:49 pm | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 10,014 | $25.76 | $257,983 | 0 (Direct) | View |
| 2021-05-03 Sale | 2021-05-06 8:03 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $24.84 | $149,051 | 54,234 (Direct) | View |
| 2021-05-03 Sale | 2021-05-06 8:06 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $24.84 | $124,197 | 42,969 (Direct) | View |
| 2021-05-03 Sale(A) | 2021-05-07 6:05 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $24.84 | $149,051 | 48,234 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 6:26 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 34,000 | $26.72 | $908,361 | 14,234 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 6:28 pm | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $26.83 | $201,221 | 0 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 7:29 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 8,933 | $30.05 | $268,480 | 145,737 (Direct) | View |
| 2021-06-17 Sale | 2021-06-22 5:15 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,067 | $30.04 | $32,051 | 144,670 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 5:35 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $24.15 | $241,477 | 134,670 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-16 Option Award | 2020-12-18 5:58 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 140,000 | $0 | 140,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:01 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:02 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:05 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:08 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:13 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $6.74 | 32,858 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:06 pm | N/A 2026-12-28 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $0 | 59,253 (Direct) | View |
| 2021-01-04 Gift | 2021-01-06 5:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,000 | $0 | 179,420 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:32 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:32 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 12,500 | $0 | 85,234 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:33 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:33 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:33 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:33 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 32,500 | $0 | 65,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:34 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 37,500 | $0 | 37,500 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:34 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:35 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:35 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 31,000 | $0 | 31,000 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:35 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-02-23 Exercise | 2021-02-25 8:23 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 29,642 | $6.74 | 94,642 (Direct) | View |
| 2021-02-23 Exercise | 2021-02-25 8:23 pm | N/A 2026-12-28 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 29,642 | $0 | 29,611 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-19 7:49 pm | N/A 2031-03-17 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 11,017 | $7.91 | 11,017 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 36,127 | $7.91 | 36,127 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 12,856 | $7.91 | 12,856 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 14,662 | $8.21 | 27,518 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 13,368 | $16.08 | 40,886 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A 2027-03-07 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 11,017 | $0 | 48,983 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A 2027-03-07 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 36,127 | $0 | 12,856 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A 2027-03-07 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 12,856 | $0 | 0 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A 2028-06-03 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 14,662 | $0 | 6,038 (Direct) | View |
| 2021-04-27 Exercise | 2021-04-29 8:55 pm | N/A 2028-09-17 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 13,368 | $0 | 7,332 (Direct) | View |
| 2021-04-28 Exercise | 2021-04-30 5:49 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 10,014 | $8.39 | 10,014 (Direct) | View |
| 2021-04-28 Exercise | 2021-04-30 5:49 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 10,014 | $0 | 30,096 (Direct) | View |
| 2021-05-01 Option Award | 2021-05-04 5:36 pm | N/A 2031-04-30 | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-06 8:03 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $10.21 | 60,234 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-06 8:03 pm | N/A 2026-11-27 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $0 | 20,255 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:20 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-26 Gift | 2021-05-28 5:23 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 4,750 | $0 | 154,670 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:23 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:25 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:26 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:28 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:29 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $8.39 | 7,500 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $0 | 22,596 (Direct) | View |